Literature DB >> 33594825

Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015.

Feifan He1, Junyi Wang1, Li Liu2, Xiaoyue Qin1, Zhanyong Wan1, Wei Li1, Zhiguang Ping1.   

Abstract

BACKGROUND: The long-term trend analysis of esophageal cancer is rarely reported in China. Our purpose is to analyze the incidence and mortality trends of esophageal cancer in China from 2005 to 2015.
METHOD: Based on the data in the annual report of the China Cancer Registry, a comprehensive analysis of esophageal cancer cases and deaths from 2005 to 2015 was carried out. The incidence and mortality of esophageal cancer are stratified by gender and region (urban or rural). Long-term trend analysis was conducted using Joinpoint regression model. RESULT: In China, the age-standardized incidence rates by the world population declined from 13.84/105 in 2005 to 11.64/105 in 2015. Annual percent changes were 3.4% (95% CI: 0.6%, 6.3%) in the period 2005-2011, -7.4% (95% CI: -10.1%, -4.7%) in the period 2011-2015, respectively. The age-standardized mortality rates declined from 10.86/105 in 2005 to 8.57/105 in 2015. And the average annual percent change was -4.1% (95% CI: -6.7%, -1.5%). The incidence and mortality of esophageal cancer in men are higher than those in women, and the incidence and mortality of esophageal cancer in rural areas are much higher than those in urban areas.
CONCLUSION: In China, the incidence of esophageal cancer first increased and then decreased during 2005-2015, while the mortality rate has been declining.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  China; Esophageal cancer; incidence or morbidity; mortality; trend

Mesh:

Year:  2021        PMID: 33594825      PMCID: PMC7940233          DOI: 10.1002/cam4.3647

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  19 in total

1.  Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012.

Authors:  Wen-Rui Tang; Jia-Ying Fang; Ku-Sheng Wu; Xiao-Jun Shi; Jia-Yi Luo; Kun Lin
Journal:  Asian Pac J Cancer Prev       Date:  2014

2.  [The 2015 China Adult Tobacco Survey: exposure to second-hand smoke among adults aged 15 and above and their support to policy on banning smoking in public places].

Authors:  Y Nan; Z Xi; Y Yang; L L Wang; M W Tu; J J Wang; Y Jiang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2016-06

3.  Geographic distribution and time trends of esophageal cancer in Brazil from 2005 to 2015.

Authors:  César Augusto Amorim; Lucila Perrota De Souza; Jessica P Moreira; Ronir R Luiz; Antonio José De V Carneiro; Heitor S P De Souza
Journal:  Mol Clin Oncol       Date:  2019-04-10

4.  Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening.

Authors:  Guo-Qing Wang; Guang-Gen Jiao; Fu-Bao Chang; Wei-Hong Fang; Jin-Xiang Song; Ning Lu; Dong-Mei Lin; Yong-Qiang Xie; Ling Yang
Journal:  Ann Thorac Surg       Date:  2004-05       Impact factor: 4.330

5.  Efficacy of endoscopic treatment on patients with severe dysplasia/carcinoma in situ of esophageal squamous cell carcinoma: A prospective cohort study.

Authors:  Meng Wang; Changqing Hao; Shuanghua Xie; Shanrui Ma; Qing Ma; Rongshou Zheng; Ru Chen; Xinqing Li; Wenqiang Wei
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

6.  Annual cost of illness of stomach and esophageal cancer patients in urban and rural areas in China: A multi-center study.

Authors:  Zhixun Yang; Hongmei Zeng; Ruyi Xia; Qian Liu; Kexin Sun; Rongshou Zheng; Siwei Zhang; Changfa Xia; He Li; Shuzheng Liu; Zhiyi Zhang; Yuqin Liu; Guizhou Guo; Guohui Song; Yigong Zhu; Xianghong Wu; Bingbing Song; Xianzhen Liao; Yanfang Chen; Wenqiang Wei; Guihua Zhuang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2018-08       Impact factor: 5.087

7.  Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.

Authors:  Aesun Shin; Young-Joo Won; Hye-Kyung Jung; Hyun-Joo Kong; Kyu-Won Jung; Chang-Mo Oh; Sunho Choe; Jihyun Lee
Journal:  J Gastroenterol Hepatol       Date:  2018-06-12       Impact factor: 4.029

8.  Incidence and mortality of esophagus cancer in China, 2008-2012.

Authors:  Yutong He; Daojuan Li; Baoen Shan; Di Liang; Jin Shi; Wanqing Chen; Jie He
Journal:  Chin J Cancer Res       Date:  2019-06       Impact factor: 5.087

9.  Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015.

Authors:  Feifan He; Junyi Wang; Li Liu; Xiaoyue Qin; Zhanyong Wan; Wei Li; Zhiguang Ping
Journal:  Cancer Med       Date:  2021-02-16       Impact factor: 4.452

10.  Tracking MPOWER in 14 countries: results from the Global Adult Tobacco Survey, 2008-2010.

Authors:  Yang Song; Luhua Zhao; Krishna Mohan Palipudi; Samira Asma; Jeremy Morton; Brandon Talley; Jason Hsia; Nivo Ramanandraibe; Roberta Caixeta; Heba Fouad; Rula Khoury; Dhirendra Sinha; James Rarick; Douglas Bettcher; Armando Peruga; Katherine Deland; Edouard Tursan D'Espaignet
Journal:  Glob Health Promot       Date:  2013-09-16
View more
  13 in total

1.  Combining the systemic inflammation response index and prognostic nutritional index to predict the prognosis of locally advanced elderly esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.

Authors:  Ke Yan; Wanyi Wei; Wenbin Shen; Xingyu Du; Shuchai Zhu; Hanjun Zhao; Xiaobin Wang; Jie Yang; Xueyuan Zhang; Wenzhao Deng
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  The effectiveness of telephone and internet-based supportive care for patients with esophageal cancer on enhanced recovery after surgery in China: A randomized controlled trial.

Authors:  Yuan Yu; Min Li; Ran Kang; Xinzhe Liu; Nuoxiaoxuan Wang; Qingmiao Zhu; Jun Cao; Minghua Cong
Journal:  Asia Pac J Oncol Nurs       Date:  2022-03-05

3.  Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study.

Authors:  Song Zhang; Xin Wang; Hao Gu; Jun-Qi Liu
Journal:  Cancer Manag Res       Date:  2022-05-13       Impact factor: 3.602

4.  Expression of the CLCA4 Gene in Esophageal Carcinoma and Its Impact on the Biologic Function of Esophageal Carcinoma Cells.

Authors:  Xin Song; Shuai Zhang; Shouchuan Li; Ye Wang; Xinming Zhang; Feng Xue
Journal:  J Oncol       Date:  2021-06-04       Impact factor: 4.375

5.  Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015.

Authors:  Feifan He; Junyi Wang; Li Liu; Xiaoyue Qin; Zhanyong Wan; Wei Li; Zhiguang Ping
Journal:  Cancer Med       Date:  2021-02-16       Impact factor: 4.452

6.  Neoadjuvant Immunotherapy Combined Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study.

Authors:  Zhi-Nuan Hong; Kai Weng; Kaiming Peng; Zhen Chen; Jihong Lin; Mingqiang Kang
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

7.  Neoadjuvant sintilimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, single-center, phase 2 trial (ESONICT-1).

Authors:  Zhenyang Zhang; Zhi-Nuan Hong; Shuhan Xie; Jiangbo Lin; Mingqiang Kang; Wenwei Lin; Yukang Lin; Jiafu Zhu; Xiaojie Yang; Zhiwei Lin
Journal:  Ann Transl Med       Date:  2021-11

Review 8.  Oral microbiota in human systematic diseases.

Authors:  Xian Peng; Lei Cheng; Yong You; Chengwei Tang; Biao Ren; Yuqing Li; Xin Xu; Xuedong Zhou
Journal:  Int J Oral Sci       Date:  2022-03-02       Impact factor: 24.897

9.  Safety and Feasibility of Esophagectomy Following Combined Immunotherapy and Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Analysis.

Authors:  Zhi-Nuan Hong; Lei Gao; Kai Weng; Zhixin Huang; Wu Han; Mingqiang Kang
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

10.  Selective synergistic anticancer effects of cisplatin and oridonin against human p53-mutant esophageal squamous carcinoma cells.

Authors:  Huiyu Yang; Jie Wang; Suliman Khan; Yuanying Zhang; Kuicheng Zhu; Enhui Zhou; Meiyuan Gong; Bingrong Liu; Quancheng Kan; Qi Zhang
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.